Fukushima Medical University
福島県立医科大学 学術機関リポジトリ
This document is downloaded at: 2021-11-08T01:52:18Z
Title 多発性硬化症治療学講座( 論文・著書・発表等 )
Author(s)
Citation 福島県立医科大学業績集. 30: 403-405
Issue Date 2020-03-19
URL http://ir.fmu.ac.jp/dspace/handle/123456789/1222
Rights ©2020 福島県立医科大学
DOI
Text Version publisher
多発性硬化症治療学講座
論 文
〔原 著〕
Asato Y, Kamitani T, Ootsuka K, Kuramochi M, Nakanishi K, Shimada T, Takahashi T, Misu T, Aoki M, Fujihara K, Kawabata Y. A Case of Transient Pulmonary Interstitial Lesions in Aquaporin-4-positive Neuromyelitis Optica Spectrum Disorder. Internal Medicine. 201810; 7(20):2981-2986.
Miyamoto K, Fujihara K, Kira J, Kuriyama N, Matsui M, Tamakoshi A, Kusunoki S. Nationwide
epidemiological study of neuromyelitis optica in Japan. Journal of Neurology, Neurosurgery, and Psychiatry.
201806; 89(6):667-668.
Kaneko K, Sato DK, Nakashima I, Ogawa R, Akaishi T, Takai Y, Nishiyama S, Takahashi T, Misu T, Kuroda H, Tanaka S, Nomura K, Yuji Hashimoto Y, Callegaro D, Steinman L, Fujihara K, Aoki M. CSF cytokine profile in MOG-IgG+neurologic disease is similar to AQP4-IgG+NMOSD but distinct from MS: a cross- sectional study and potential therapeutic implications. Journal of Neurology, Neurosurgery, and Psychiatry.
201809; 89(9):927-936.
Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintore M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA. Diagnosis of Multiple Sclerosis: 2017 Revisions of the McDonald Criteria. Lancet Neurology. 201802; 17(2):162-173.
Matsumoto Y Norshalena S, Tsuchiya M, Kaneko C, Kubo J, Yamamoto T, Takahashi T, Fujihara K. Severe aquaporin 4-IgG-positive neuromyelitis optica with disseminated herpes zoster in a pregnant woman successfully treated with intravenous immunoglobulins. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 201803; 4(1):2055217318758110.
Nishiyama S, Misu T, Shishido-Hara Y, Nakamichi K, Saijo M, Takai Y, Takei K, Yamamoto N, Kuroda H, Saito R5, Watanabe M, Tominaga T, Nakashima I, Fujihara K, Aoki M. Fingolimod-associated PML with mild IRIS in MS: A clinicopathological study. Neurology: Neuroimmunology & Neuroinflammation. 201801;
5(1):e415.
Shosha E, Dubey D, Palace J, Nakashima I, Jacob A, Fujihara K, Takahashi T, Whittam D, Leite MI, Misu T, Takai Y, Messina S, Elsone L, Majed M, Flanagan E, Gadoth A, Huebert C, Sagen J, Greenberg BM, Levy M, Banerjee A, Weinshenker B, Pittock SJ. Area Postrema Syndrome: Frequency, Criteria and Severity in AQP4-IgG positive NMOSD. Neurology. 201810; 91(17):e1642-e1651.
小林奈美江, 小野田貴嗣, 小林健太郎, 永沼和香子, 藤原一男. 虚血性心疾患によって発症した若年発症の両
－403－
眼非動脈炎型虚血性視神経症の1例. 臨床眼科. 201809; 72(9):1241-1247.
〔総説等〕
Fujihara K, Sato DK, Nakashima I, Takahashi T, Kaneko K, Ogawa R, Akaishi T, Matsumoto Y, Takai Y, Nishiyama S, Kuroda H, Misu T, Aoki M. Myelin oligodendrocyte glycoprotein immunoglobulin G‐associated disease: An overview. Clinical and Experimental Neuroimmunology. 201803; 9(Suppl.1):48-55.
dos Passos GR, Oliveira LM, da Costa BK, Apostolos-Pereira SL, Callegaro D, Fujihara K, Sato DK.
MOG-IgG-associated optic neuritis, encephalitis, and myelitis (MONEM): lessons learned from neuromyelitis optica spectrum disorder. Frontiers in Neurology. 201804; 9:217.
Jarius S, Paul F, Aktas O, Asgari N, Dale RC, de Seze J, Franciotta D, Fujihara K, Jacob A, Kim HJ, Kleiter I, Kumpfel T, Levy M, Palace J, Ruprecht K, Saiz A, Trebst C, Weinshenker BG, Wildemann B.
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. Journal of Neuroinflammation. 201805; 15(1):134.
Jarius S, Paul F, Aktas O, Asgari N, Dale RC, de Seze J, Franciotta D, Fujihara K, Jacob A, Kim HJ, Kleiter I, Kumpfel T, Levy M, Palace J, Ruprecht K, Saiz A, Trebst C, Weinshenker BG, Wildemann B.
MOG-Enzephalomyelitis: Internationale Empfehlungen zu Diagnose und Antikörpertestung. Nervenarzt.
201809; 89:1388-1399.
松本勇貴, 藤原一男. 中枢神経系脱髄疾患－最前線抗MOG抗体の関与を考える 視神経脊髄炎関連疾患と抗
AQP4抗体 NMOSDの診断基準. Clinical Neuroscience. 201811; 36(11):1306-1309.
越智博文, 藤原一男. 神経難病と創薬 多発性硬化症の創薬の展望. 医薬ジャーナル. 201807; 54(7):1661-1667.
北山通朗, 藤原一男. 研修医が知っておきたい神経疾患の診断と治療 脱髄性疾患. 月刊レジデント. 201812;
11(10):56-67.
藤原一男. 神経脊髄炎 多発性硬化症との相違点. 東京都医師会雑誌. 201806; 71(5):384-388.
著 書・訳 書
藤原一男. 多発性硬化症と視神経脊髄炎. In: 水澤英洋, 山口修平, 園生雅弘編. 神経疾患最新の治療 2018-2020.
東京: 南江堂; 201801. p.156-159.
藤原一男. V. 診断 2. NMOの診断はどうしますか、診断ガイドラインはどのようなものがあり、どう利用すれ ばよいでしょうか. In: 神田 隆編. 中枢脱髄性疾患(神経内科Clinical Questions and Pearls). 東京: 中外医学社; 201801. p.195-202.
藤原一男. 視神経脊髄炎. In: 福井次矢, 高木 誠, 小室一成 編. 今日の治療指針 2018年版. 東京: 医学書院; 201801. p.922-923.
－404－
藤原一男. 多発性硬化症治療薬. In: 小松康宏, 渡邉裕司編. Pocket Drugs 2018. 東京: 医学書院; 201801. p.75- 80.
研究発表等
〔招待講演〕
Fujihara K. Diagnostic criteria of MS and NMO. XXI Symposium Neuroradiogicum (SNR 2018); 20180323;
Taipei, Taiwan.
Fujihara K. Geoepidemiology: World atlas of NMO. NMO state of the union, building on success: the next decade of NMO. 10th Annual International NMO Roundtable Conference; 20180421; Los Angeles, USA.
Fujihara K. Predominantly spinal MS versus seronegative NMOSD: diagnostic issues. 19th Annual Congress of Brazilian Committee for Treatment and Research in multiple Sclerosis (BCTRIMS); 20180802; Sao Paulo, Brazil.
Fujihara K. Was anything left aside in the 2017 McDonald criteria for the diagnosis of MS? 19th Annual Congress of Brazilian Committee for Treatment and Research in multiple Sclerosis (BCTRIMS); 20180802;
Sao Paulo, Brazil.
Fujihara K. Teaching Course 23: NMOSD Current concept and clinical management: MOG-antibody disease update and differentiation from MS and AQP4-antibody positive disease. 34th Congress of European Committee on Treatment and Research in Multiple Sclerosis (ECTRIMS); 20181010-12; Berlin, Germany.
Fujihara K. NMO Spectrum Disorders: an Update. 3rd Russian Committee for Treatment and Research in Multiple Sclerosis (RUCTRIMS); 20180914-16; Ekaterinburg, Russia.
Fujihara K. Toward approved NMOSD therapeutics: clinical perspectives. Guthy-Jackson Charitable Foundation NMO Symposium (Global Partnerships for Cures); 20181009; Berlin, Germany.
Fujihara K. Symposium-3: Comprehensive Management of MS and NMOSD in Asia-Pacific Regions L-13 The Approach to the Management of Indeterminate MS/NMOSD. 11th Pan-Asian Committee for Treatment and Research in Multiple Sclerosis (PACTIRMS); 20181101-03; Sydney, Australia.
Fujihara K. Plenary Session 2: Demyelinating Disorders, Diagnostic approach in CNS Demyelinating Diseases.
16th Asian Oceanian Congress of Neurology; 20181110; Seoul, Korea.
Fujihara K. Session V - Long term observation of diseases at the border of MS and of pediatric MS: NMO Spectrum Disorders. 26th Annual Meeting of European Charcot Foundation; 20181116; Baveno, Italy.
－405－
